Promacta (Eltrombopag): Uses, Risks, and Treatment Insights

Promacta (generic name Eltrombopag) is an oral medication that helps increase the platelet count in patients with thrombocytopenia, a condition characterized by low platelet levels in the blood.

This condition can result from several medical conditions, including chronic immune thrombocytopenia (ITP), hepatitis C, and severe aplastic anemia.

Key Details 

Feature	Details
Drug Class	Thrombopoietin receptor agonist
Brand Name	Promacta (Eltrombopag)
Common Uses	Treatment of thrombocytopenia (low platelet count) in conditions such as chronic immune thrombocytopenia (ITP), hepatitis C, and severe aplastic anemia
Administration Route	Oral tablets, oral suspension
Typical Dosage	25 mg to 75 mg per day depending on the condition being treated
Side Effects	Nausea, fatigue, headache, elevated liver enzymes, gastrointestinal bleeding
Serious Side Effects	Liver toxicity, cataracts, blood clots, bone marrow fibrosis
Monitoring Requirements	Liver function tests, complete blood count (CBC), eye exams for cataracts
Contraindications	Liver disease, history of blood clots, pregnancy (caution)
Precautions	Use with caution in those with liver disease or a history of blood clots

 

How Promacta Works

Promacta acts by mimicking the action of a naturally occurring protein in the body called thrombopoietin. Thrombopoietin is responsible for regulating the production of platelets in the bone marrow.

In patients with thrombocytopenia, the body either doesn’t produce enough thrombopoietin or the bone marrow doesn’t respond adequately to it.

Promacta binds to the thrombopoietin receptor on the surface of the platelet precursor cells in the bone marrow, stimulating the production of platelets.

MUST READ: Prolia Injection: How It Works, Risks, and Treatment Overview

This helps increase the platelet count in the bloodstream, making it less likely for the patient to experience excessive bleeding or other complications associated with low platelets.

Uses of Promacta

Promacta is used to treat thrombocytopenia in several medical conditions, including:

• Chronic Immune Thrombocytopenia (ITP):
  This is an autoimmune disorder where the immune system attacks and destroys platelets. Promacta is prescribed when other treatments, like steroids or immunoglobulins, have not been effective.
• Hepatitis C-Induced Thrombocytopenia:
  Chronic hepatitis C infection can lead to low platelet levels, particularly in patients who are receiving interferon-based therapy. Promacta can be used to increase platelet counts in these patients, helping them tolerate treatments better.
• Severe Aplastic Anemia:
  Aplastic anemia is a rare condition in which the bone marrow fails to produce enough blood cells, including platelets. Promacta helps stimulate platelet production in these patients, preventing complications like bleeding and bruising.

How is Promacta Taken?

Promacta is available in the form of oral tablets and an oral suspension. The dosage depends on the condition being treated and the patient’s response to the medication.

Typical Dosage

• Chronic Immune Thrombocytopenia (ITP):
  The usual starting dose for ITP patients is 50 mg per day, which may be adjusted based on platelet count and individual response. In some cases, the dose may be reduced to 25 mg or increased up to 75 mg per day.
• Hepatitis C:
  For patients with hepatitis C-induced thrombocytopenia, the recommended dose is typically 25–75 mg daily.
• Severe Aplastic Anemia:
  In cases of severe aplastic anemia, 50 mg per day is the usual starting dose, which can be adjusted depending on blood counts and platelet response.

The tablets should be taken on an empty stomach, at least 1 hour before or 2 hours after meals. For the oral suspension form, a special measuring device should be used to ensure the correct dose.

Potential Side Effects of Promacta

While Promacta is effective in increasing platelet counts, it can cause a variety of side effects. Some of the more common side effects include:

Common Side Effects:

• Nausea and vomiting
• Fatigue and weakness
• Headache
• Gastrointestinal issues, including diarrhea, stomach pain, and indigestion
• Elevated liver enzymes, which may indicate potential liver problems

Serious Side Effects:

• Liver toxicity: Promacta can cause liver damage in some patients, which may lead to liver failure if not detected early. Regular liver function tests are necessary to monitor for signs of toxicity.
• Blood clots: There is an increased risk of developing blood clots (thrombosis), especially in patients with pre-existing conditions like hepatic disease or history of clots.
• Bone marrow fibrosis: Long-term use of Promacta can lead to scarring or fibrosis in the bone marrow, which may impair blood cell production.
• Cataracts: There have been reports of cataracts developing in some patients taking Promacta long-term, particularly in children. Eye exams should be performed regularly.

Contraindications and Cautions

Promacta should not be used in patients with certain conditions, and caution should be exercised in specific populations:

• Liver disease: Patients with active liver disease, such as cirrhosis or hepatitis, should avoid Promacta, as the drug may exacerbate liver issues.
• Blood clotting disorders: Individuals with a history of blood clots, including deep vein thrombosis (DVT) or pulmonary embolism, may have an increased risk of clot formation.
• Pregnancy and breastfeeding: Promacta is categorized as Pregnancy Category C, meaning it may cause harm to a fetus. Women who are pregnant or breastfeeding should consult their healthcare provider before starting treatment with Promacta.
• Children: Long-term use of Promacta in children should be approached with caution, as it may increase the risk of cataracts and other side effects. Regular eye exams are recommended.

Conclusion

Promacta (Eltrombopag) is a highly effective medication for treating thrombocytopenia in conditions like chronic immune thrombocytopenia (ITP), hepatitis C, and severe aplastic anemia. By stimulating platelet production, Promacta helps to reduce the risk of bleeding and improve quality of life for patients with low platelet counts. However, like all medications, Promacta carries potential risks, such as liver toxicity, blood clots, and bone marrow issues. Close monitoring through regular blood tests, liver function tests, and eye exams is crucial for ensuring safe use. As with any treatment, it is important to follow your healthcare provider’s instructions and attend regular follow-up appointments.

People May Ask

What is Promacta used for?

Promacta is used to treat thrombocytopenia (low platelet count) in conditions such as chronic immune thrombocytopenia (ITP), hepatitis C, and severe aplastic anemia.

How does Promacta work?

Promacta works by stimulating the thrombopoietin receptor in the bone marrow, leading to increased platelet production and higher platelet counts in the bloodstream.

What are the common side effects of Promacta?

Common side effects include nausea, fatigue, headache, elevated liver enzymes, and gastrointestinal discomfort.

Can Promacta cause liver damage?

Yes, liver toxicity is a potential side effect of Promacta. Regular liver function tests are essential during treatment to monitor for any signs of liver damage.

Who should avoid Promacta?

Promacta should be avoided by patients with liver disease, a history of blood clots, or those who are pregnant or breastfeeding. Always consult your healthcare provider before starting treatment.

Click here to learn more.